These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1398521)

  • 61. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
    Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prostate tumour markers and differentiation grade in prostatic cancer.
    Haapiainen RK; Permi EJ; Rannikko SA; Voutilainen PE; Alfthan OS
    Br J Urol; 1990 Dec; 66(6):635-8. PubMed ID: 1702339
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.
    Singhi AD; Seethala RR; Nason K; Foxwell TJ; Roche RL; McGrath KM; Levy RM; Luketich JD; Davison JM
    Hum Pathol; 2015 Mar; 46(3):366-75. PubMed ID: 25582499
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections.
    Mohler JL; Partin AW; Epstein JI; Lohr WD; Coffey DS
    J Urol; 1988 May; 139(5):1085-90. PubMed ID: 3283380
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
    Shah RB; Magi-Galluzzi C; Han B; Zhou M
    Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Digital image analysis of proliferative index: two distinct populations of high-grade prostatic intraepithelial neoplasia in close proximity to adenocarcinoma of the prostate.
    Weinstein MH
    Hum Pathol; 1998 Jun; 29(6):620-6. PubMed ID: 9635684
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bcl-2 correlates with tumor ploidy and nuclear morphology in early stage prostate carcinoma. A fine needle aspiration biopsy study.
    Maffini MV; Ortega HH; Stoker C; Giardina RH; Luque EH; Muñoz de Toro MM
    Pathol Res Pract; 2001; 197(7):487-92. PubMed ID: 11482579
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.
    Oxley JD; Abbott CD; Gillatt DA; MacIver AG
    Br J Urol; 1998 Jan; 81(1):109-15. PubMed ID: 9467486
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Puncture biopsy of the prostate].
    Lechevallier E
    Prog Urol; 1996; 6(4):507-18. PubMed ID: 8924925
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Large cell undifferentiated carcinoma of the urinary bladder.
    Lopez-Beltran A; Cheng L; Comperat E; Rouprêt M; Blanca A; Menendez CL; Montironi R
    Pathology; 2010 Jun; 42(4):364-8. PubMed ID: 20438410
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The natural course of prostatic carcinoma in relation to initial cytological grade.
    Adolfsson J; Fåhraeus B
    J Urol; 1988 Dec; 140(6):1452-4. PubMed ID: 3193514
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence.
    Jones TD; Koch MO; Lin H; Cheng L
    BJU Int; 2005 Dec; 96(9):1253-7. PubMed ID: 16287440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Cytological and immunocytochemical study of prostatic carcinoma cell in voided urine. Usefulness of prostate-specific antigen in cytology specimen].
    Kaneoka A; Kawabe T; Takasu K
    Rinsho Byori; 1990 Nov; 38(11):1295-300. PubMed ID: 1703246
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
    Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
    Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Histological evaluation of prostatic cancer. (III): Reproducibility of assessment of tumour volume and its possible significance for prognosis.
    Svanholm H; Starklint H; Barlebo H; Olsen S
    APMIS; 1990 Mar; 98(3):237-43. PubMed ID: 2317347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.